News & Events
Default Interior Banner

Author Archives for UroLift

Research Reinforcing the Effectiveness and Safety of the UroLift® System in the Real-World Setting Presented at 50th Annual ICS Meeting

November 24, 2020 3:08 am by

New Findings Show UroLift System Same-Day Outpatient Procedure Demonstrates Symptom Improvement for Benign Prostatic Hyperplasia WAYNE, Pa.— November 19, 2020 – Teleflex Incorporated (NYSE: TFX) today announced the results of four studies that were accepted at the ICS 2020 Annual Meeting – Online reinforcing the safety and efficacy of the UroLift® System for the treatment of benign prostatic hyperplasia (BPH).... Read More


Teleflex COVID-19 Response

April 17, 2020 1:34 am by

The Teleflex mission to improve the health and quality of people’s lives has taken on a new meaning during the COVID‑19 pandemic.... Read More


Teleflex Announces Urology Times Article Highlighting the UroLift System as Providing a Superior Patient Experience for Treating Enlarged Prostate

September 16, 2019 7:46 am by

Minimally Invasive Treatment Options for BPH Remain Critical Due to Shortcomings of Surgery and Medication WAYNE, Pa. –Sept. 16, 2019 – Teleflex Incorporated (NYSE: TFX) today announced the publication of an article showcasing the effectiveness and overall benefits of the minimally invasive UroLift® System treatment for patients with benign prostatic hyperplasia (BPH).... Read More